Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
FRA:36X'
s OCF Yield % Range Over the Past 10 Years
Min: -25.42 Med: -10.65 Max: 1.79
Current: 1.79
During the past 10 years, the highest OCF Yield % of Ascentage Pharma Group International was 1.79%. The lowest was -25.42%. And the median was -10.65%.
FRA:36X's OCF Yield % is ranked better than 83.4% of 1410
companies
in the Biotechnology industry
Industry Median: -8.295
vs FRA:36X: 1.79
Ascentage Pharma Group International OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ascentage Pharma Group International OCF Yield % Related Terms
Ascentage Pharma Group International OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International OCF Yield % Chart
FRA:36X vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Ascentage Pharma Group International's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascentage Pharma Group International OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Ascentage Pharma Group International's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International (FRA:36X) has a OCF Yield % of 1.79 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ascentage Pharma Group International and its competitors. According to the industry distribution chart, Ascentage Pharma Group International ranks #234 out of 1410 companies in the Biotechnology industry, placing it in the top 16.6%.
Is Ascentage Pharma Group International's OCF Yield % too high?
Ascentage Pharma Group International's current OCF Yield % is 1.79. Based on the distribution chart, Ascentage Pharma Group International ranks #234 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ascentage Pharma Group International has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Ascentage Pharma Group International's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ascentage Pharma Group International ranks #234 out of 1410 companies for OCF Yield %. This places Ascentage Pharma Group International in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ascentage Pharma Group International and its competitors. Ascentage Pharma Group International's current OCF Yield % is 1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascentage Pharma Group International stock overvalued right now?
Ascentage Pharma Group International (FRA:36X) has a current OCF Yield % of 1.79. The stock's GF Value™ is €4.49, compared to a current price of €3.80 — trading 15.4% below its estimated fair value. The current OCF Yield % is 1.79. Ascentage Pharma Group International's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ascentage Pharma Group International (FRA:36X), the current OCF Yield % is 1.79 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascentage Pharma Group International (FRA:36X) Overvalued in 2026?
Based on GuruFocus' analysis, Ascentage Pharma Group International stock appears to be undervalued.
The current stock price of €3.80 is trading 15.4% below its estimated GF Value™ of €4.49.
Key valuation signals for FRA:36X:
OCF Yield %: 1.79
GF Value™: €4.49 vs. price of €3.80 (15.4% below fair value)
No single metric tells the full story. See the FRA:36X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascentage Pharma Group International Business Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
68GF Score
Get the complete analysis for FRA:36X
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:36X has been successfully added to your 
